
Professor Henrik Watz explores the complex relationship between inflammation and COPD, highlighting its impact on patients' health and overall quality of life.

September 25th marks this year’s observance and celebration of World Lung Day!
Professor Mona Bafadhel presents a comprehensive overview of type 2 inflammation in COPD, exploring its underlying mechanisms, clinical manifestations, and implications for patient outcomes.

Professor Alberto Papi presents the latest clinical data on current and emerging biologics for COPD with type 2 inflammation.
Professors Henrik Watz, Mona Bafadhel, and Alberto Papi discuss the pathophysiology of COPD with type 2 inflammation and review current and emerging biologic therapies

Join experts Henrik Watz, Mona Bafadhel, and Alberto Papi for an educational symposium on the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden, exploring the role of type 2 cytokines, and current and emerging therapies.

Learn about the disease burden and heterogeneity of chronic obstructive pulmonary disease (COPD).

Understand the drivers of lung function decline in chronic obstructive pulmonary disease (COPD), including chronic inflammation, key risk factors, and the impact on patient well-being .
Learn about the significant burden that patients with COPD experience and the role of inflammatory mechanisms in this chronic, often progressive disease.

Dr. Mario Castro discusses how COPD exacerbations can predict future exacerbations and lead to progressive lung function loss in COPD patients.

Welcome to the COPD learning hub focused on key scientific education on chronic obstructive pulmonary disease, featuring ADVENT resources.
Brian Lipworth, MD, is a leading respiratory physician and researcher affiliated with Ninewells Hospital and Medical School, University of Dundee, Scotland, UK. His extensive body of work, reflected in highly cited publications, focuses on asthma and chronic obstructive pulmonary disease (COPD).